Comparison XORTX Therapeutics (XRTX) with Competitors
XORTX Therapeutics (XRTX) industry is Biotechnology.
Debt-to-Equity
XRTX1.17%
Industry28.27%
Upside-95.85%
Free Cash Flow Yield
XRTX-68.74%
Industry-1.75%
Upside-66.99%
Forward P/E
XRTX0.96
Industry16.35
Upside-94.12%
P/B
XRTX3.05
Industry5.15
Upside-40.82%